Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|October 4, 2014
Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptorTetsuaki Hiyoshi, Toshiyuki Marumo, Hirohiko Hikichi, et al.Journal of Pharmacological Sciences|February 2, 2012
The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced abnormal behaviors in miceYukio Ago, Ryota Araki, Koji Yano, et al.Journal of Pharmacological Sciences|April 4, 2015
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptorHirohiko Hikichi, Tetsuaki Hiyoshi, Toshiyuki Marumo, et al.Neuropharmacology|October 26, 2010
Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared miceToshiyuki Kawasaki, Yukio Ago, Koji Yano, et al.Neuropharmacology|February 21, 2004
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activityShigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, et al.Psychopharmacology|April 14, 2011
Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmissionYukio Ago, Ryota Araki, Koji Yano, et al.Bioorganic & Medicinal Chemistry|January 26, 2006
Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically stable melanin-concentrating hormone receptor 1 antagonistsKosuke Kanuma, Katsunori Omodera, Mariko Nishiguchi, et al.Bioorganic & Medicinal Chemistry Letters|July 9, 2005
Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1Kosuke Kanuma, Katsunori Omodera, Mariko Nishiguchi, et al.European Journal of Medicinal Chemistry|July 23, 2020
Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailabilityHiroki Urabe, Naoki Miyakoshi, Norikazu Ohtake, et al.Neuropharmacology|October 2, 2012
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in miceYukio Ago, Koji Yano, Ryota Araki, et al.Pageof 14